ID CHO-TPO-2B AC CVCL_E3EH RX PubMed=1936519; CC Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX). CC Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line). CC Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12015; TPO. CC Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr. CC Transformant: NCIt; C129640; Cobalt-60 gamma radiation. CC Derived from site: In situ; Ovary; UBERON=UBERON_0000992. CC Cell type: Epithelial cell of ovary; CL=CL_2000064. OX NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster) HI CVCL_7180 ! CHO-DG44 SX Female AG Adult CA Transformed cell line DT Created: 19-12-24; Last updated: 19-12-24; Version: 1 // RX PubMed=1936519; DOI=10.1016/0303-7207(91)90191-t; RA Kaufman K.D., Foti D.P., Seto P., Rapoport B.; RT "Overexpression of an immunologically-intact, secreted form of human RT thyroid peroxidase in eukaryotic cells."; RL Mol. Cell. Endocrinol. 78:107-114(1991). //